Skip to main content
Livermore
Livermore
ZHEN

Mineralys Therapeutics, Inc.

MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001933414

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Mineralys Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of MLYS: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders068+68
Shares024.6M+24.6M
Value$0$385.4M+$385.4M

New holders (68)

Institutions that held Mineralys Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to MLYS in Q1 2023
InstitutionSharesValue% of portfolio
Samsara BioCapital, LLC4,519,361$70.8M14.63%
Ra Capital Management, L.P.3,178,476$49.8M1.13%
Adams Street Partners LLC2,419,501$37.9M11.82%
Sr One Capital Management, LP1,794,600$28.1M10.47%
Avidity Partners Management LP1,263,800$19.8M0.66%
Rock Springs Capital Management LP1,167,492$18.3M0.44%
RTW Investments, LP922,100$14.4M0.30%
BlackRock Inc.749,689$11.7M0.00%
Deerfield Management Company, L.P. (Series C)729,021$11.4M0.25%
Laurion Capital Management LP675,136$10.6M0.48%
Great Point Partners LLC620,326$9.71M1.92%
Sectoral Asset Management Inc613,233$9.60M1.85%
Braidwell LP550,300$8.62M0.28%
Driehaus Capital Management LLC453,001$7.09M0.10%
Franklin Resources Inc450,000$7.05M0.00%
American Century Companies Inc417,903$6.53M0.01%
Jennison Associates LLC355,475$5.57M0.01%
Sphera Funds Management Ltd.339,000$5.31M1.15%
Janus Henderson Group PLC337,436$5.27M0.00%
Logos Global Management LP300,000$4.70M0.67%
Vanguard Group Inc291,728$4.57M0.00%
Geode Capital Management, LLC283,653$4.44M0.00%
Soleus Capital Management, L.P.273,241$4.28M0.53%
Citadel Advisors LLC191,048$2.99M0.00%
ExodusPoint Capital Management, LP181,312$2.84M0.03%
Woodline Partners LP175,000$2.74M0.04%
State Street Corp134,800$2.11M0.00%
Ensign Peak Advisors, Inc125,000$1.96M0.00%
Opaleye Management Inc.115,000$1.80M0.54%
Monashee Investment Management LLC110,000$1.72M0.48%
Northern Trust Corp100,477$1.57M0.00%
Charles Schwab Investment Management Inc88,960$1.39M0.00%
Schonfeld Strategic Advisors LLC88,848$1.39M0.01%
Pentwater Capital Management LP70,000$1.10M0.02%
ArrowMark Colorado Holdings LLC62,500$978.8K0.01%
Affinity Asset Advisors, LLC62,500$978.8K0.38%
Prudential Financial Inc50,570$791.9K0.00%
Alyeska Investment Group, L.P.37,500$587.3K0.01%
Point72 Middle East FZE36,822$576.6K0.03%
Bank of New York Mellon Corp33,286$521.3K0.00%
Morgan Stanley30,051$470.6K0.00%
Goldman Sachs Group Inc27,765$434.8K0.00%
Walleye Capital LLC25,996$407.1K0.01%
Wellington Management Group LLP24,224$379.3K0.00%
Nuveen Asset Management, LLC16,134$253.0K0.00%
Bank of America Corp13,990$219.1K0.00%
Barclays PLC12,536$196.3K0.00%
Rhumbline Advisers10,960$172.0K0.00%
Cubist Systematic Strategies, LLC10,227$160.2K0.00%
Parkman Healthcare Partners LLC10,000$156.6K0.03%
Ghisallo Capital Management LLC10,000$156.6K0.04%
JPMorgan Chase & Co9,269$145.0K0.00%
Deutsche Bank AG7,505$117.5K0.00%
MetLife Investment Management7,063$110.6K0.00%
American International Group, Inc.5,839$91.4K0.00%
Point72 Asset Management, L.P.5,000$78.3K0.00%
California State Teachers Retirement System4,499$70.5K0.00%
New York State Common Retirement Fund3,400$53.2K0.00%
STRS Ohio2,500$39.0K0.00%
Wells Fargo & Company2,336$36.6K0.00%
Amalgamated Bank1,543$24.0K0.00%
Tower Research Capital LLC (TRC)1,498$23.0K0.00%
Legal & General Group Plc1,273$19.9K0.00%
Ameritas Investment Partners, Inc.972$15.2K0.00%
Royal Bank of Canada894$14.0K0.00%
Metropolitan Life Insurance Co727$11.4K0.00%
FMR LLC629$9.85K0.00%
CWM, LLC13$00.00%

Sold out (0)

Institutions that held Mineralys Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

None.